These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35267031)

  • 21. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.
    Mac S; Fitzpatrick T; Johnstone J; Sander B
    Antimicrob Resist Infect Control; 2019; 8():168. PubMed ID: 31687132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for the successful control of a large outbreak of vancomycin-resistant Enterococcus faecium in a non-endemic hospital setting.
    Frakking FNJ; Bril WS; Sinnige JC; Klooster JEV; de Jong BAW; van Hannen EJ; Tersmette M
    J Hosp Infect; 2018 Dec; 100(4):e216-e225. PubMed ID: 29475013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation.
    Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L
    Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older.
    Mathis B; Haïne M; Girard R; Bonnefoy M
    BMC Geriatr; 2019 Dec; 19(1):377. PubMed ID: 31881861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Discontinuing Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: An Interrupted Time Series Analysis.
    Bearman G; Abbas S; Masroor N; Sanogo K; Vanhoozer G; Cooper K; Doll M; Stevens MP; Edmond MB
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):676-682. PubMed ID: 29580304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
    Johnstone J; Shing E; Saedi A; Adomako K; Li Y; Brown KA; Garber G
    Clin Infect Dis; 2020 Oct; 71(7):1756-1759. PubMed ID: 31922536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation.
    Ford CD; Gazdik Stofer MA; Coombs J; Lopansri BK; Webb BJ; Motyckova G; Petersen FB
    Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1055-1061. PubMed ID: 28724453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition.
    Cheah ALY; Cheng AC; Spelman D; Nation RL; Kong DCM; McBryde ES
    BMC Infect Dis; 2018 Oct; 18(1):511. PubMed ID: 30309313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.
    Martin EM; Russell D; Rubin Z; Humphries R; Grogan TR; Elashoff D; Uslan DZ
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1323-1330. PubMed ID: 27457254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive integrated NGS-based surveillance and contact-network modeling unravels transmission dynamics of vancomycin-resistant enterococci in a high-risk population within a tertiary care hospital.
    Neumann B; Bender JK; Maier BF; Wittig A; Fuchs S; Brockmann D; Semmler T; Einsele H; Kraus S; Wieler LH; Vogel U; Werner G
    PLoS One; 2020; 15(6):e0235160. PubMed ID: 32579600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.
    Puchter L; Chaberny IF; Schwab F; Vonberg RP; Bange FC; Ebadi E
    Antimicrob Resist Infect Control; 2018; 7():1. PubMed ID: 29312658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital.
    Tucci V; Haran MA; Isenberg HD
    Am J Infect Control; 1997 Oct; 25(5):371-6. PubMed ID: 9343618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
    Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
    J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of a hospital-wide vancomycin-resistant Enterococci outbreak.
    Kurup A; Chlebicki MP; Ling ML; Koh TH; Tan KY; Lee LC; Howe KB
    Am J Infect Control; 2008 Apr; 36(3):206-11. PubMed ID: 18371517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization.
    Hughes HY; Odom RT; Michelin AV; Snitkin ES; Sinaii N; Milstone AM; Henderson DK; Palmore TN
    Infect Control Hosp Epidemiol; 2019 Apr; 40(4):414-419. PubMed ID: 30729903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of discontinuing contact precautions and enforcement of basic hygiene measures on nosocomial vancomycin-resistant Enterococcus faecium transmission.
    Eichel VM; Boutin S; Frank U; Weigand MA; Heininger A; Mutters NT; Büchler MW; Heeg K; Nurjadi D
    J Hosp Infect; 2022 Mar; 121():120-127. PubMed ID: 34861314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.
    Pogue JM; Paterson DL; Pasculle AW; Potoski BA
    Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1382-8. PubMed ID: 17994519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance system.
    Dembek ZF; Kellerman SE; Ganley L; Capacchione CM; Tenover FC; Cartter ML; Van Kruiningen HJ; Jarvis WR; Hadler JL
    Infect Control Hosp Epidemiol; 1999 Oct; 20(10):671-5. PubMed ID: 10530644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors and Outcomes of Vancomycin-Resistant
    Yeung CS; Cheung CY; Chan YH; Chak WL
    Perit Dial Int; 2017; 37(5):556-561. PubMed ID: 28348103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and Outcomes of Vancomycin-Resistant Enterococcus Infections in the U.S. Military Health System.
    Stagliano DR; Susi A; Adams DJ; Nylund CM
    Mil Med; 2021 Jan; 186(Suppl 1):100-107. PubMed ID: 33499465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.